Room 311 ESMO Colloquium

ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? (ID 5)

Location
Room 311
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Chairs
  • T. Mitsudomi
  • D. Planchard
12:45 PM - 12:50 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • T. Mitsudomi

Introduction (ID 83)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
12:45 PM - 12:50 PM
Duration
5 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • T. Mitsudomi
12:50 PM - 01:10 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • R. Soo

1st line immunotherapy options for patients without an oncogene driver (ID 84)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
12:50 PM - 01:10 PM
Duration
20 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • R. Soo
01:10 PM - 01:30 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium

What is the biological rationale for combining chemotherapy with immune checkpoints inhibitors? (ID 85)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
01:10 PM - 01:30 PM
Duration
20 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
01:30 PM - 01:50 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • S. Peters

Are ICPs better as single agent, doublet ICPs or combined with Chemo +/- anti-angiogenics? (ID 86)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
01:30 PM - 01:50 PM
Duration
20 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • S. Peters
01:50 PM - 02:10 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • D. Planchard

What’s new in the guidelines for immune therapy of metastatic NSCLC? (ID 88)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
01:50 PM - 02:10 PM
Duration
20 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • D. Planchard
02:10 PM - 02:15 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • T. Mitsudomi

Conclusions (ID 89)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
02:10 PM - 02:15 PM
Duration
5 Minutes
Session Name
ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination?
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • T. Mitsudomi